Replies to post #250257 on Biotech Values

[jbog]

The biggest problem for the EDP-235 program right now is that people infected with COVID are mostly opting to do nothing and simply let the infection run its course, which is a major change in behavior from 12-24 months ago.

I see the biggest problem with EDP-235 is that ENTA themselves didn't see the results as being either robust enough or too late in the game to go forward. Period.